ロード中...

Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 β-lactamases: Raman crystallographic evidence

Tazobactam, sulbactam, and clavulanic acid are the only β-lactamase inhibitors in clinical use. Comparative inhibitory activities of clavulanic acid, sulbactam, and tazobactam against clinically important β-lactamases conclude that tazobactam is superior to both clavulanic acid and sulbactam. Thus f...

詳細記述

保存先:
書誌詳細
主要な著者: Kalp, Matthew, Totir, Monica A., Buynak, John D., Carey, Paul R.
フォーマット: Artigo
言語:Inglês
出版事項: 2009
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2661619/
https://ncbi.nlm.nih.gov/pubmed/19161282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ja808311s
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!